Invesco’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $68.1M | Buy |
1,882,499
+290,590
| +18% | +$9.93M | 0.01% | 1023 |
|
|
2026
Q1 | $52.6M | Buy |
1,591,909
+416,868
| +35% | +$17.6M | 0.01% | 1060 |
|
|
2025
Q4 | $54.4M | Sell |
1,175,041
-107,930
| -8% | -$4.52M | 0.01% | 1053 |
|
|
2025
Q3 | $44.9M | Sell |
1,282,971
-301,900
| -19% | -$10.5M | 0.01% | 1125 |
|
|
2025
Q2 | $46.9M | Sell |
1,584,871
-47,468
| -3% | -$1.35M | 0.01% | 1076 |
|
|
2025
Q1 | $48.7M | Sell |
1,632,339
-143,421
| -8% | -$4.38M | 0.01% | 1046 |
|
|
2024
Q4 | $50.9M | Buy |
1,775,760
+289,335
| +19% | +$9.57M | 0.01% | 1034 |
|
|
2024
Q3 | $57.4M | Sell |
1,486,425
-220,185
| -13% | -$7.85M | 0.01% | 989 |
|
|
2024
Q2 | $55M | Buy |
1,706,610
+74,954
| +5% | +$2.6M | 0.01% | 978 |
|
|
2024
Q1 | $63.3M | Buy |
1,631,656
+190,039
| +13% | +$6.65M | 0.01% | 945 |
|
|
2023
Q4 | $44.4M | Buy |
1,441,617
+282,013
| +24% | +$7.06M | 0.01% | 1063 |
|
|
2023
Q3 | $25.9M | Buy |
1,159,604
+19,740
| +2% | +$450K | 0.01% | 1228 |
|
|
2023
Q2 | $24.5M | Sell |
1,139,864
-239
| -0% | -$5.43K | 0.01% | 1247 |
|
|
2023
Q1 | $27.4M | Buy |
1,140,103
+72,050
| +7% | +$1.91M | 0.01% | 1196 |
|
|
2022
Q4 | $24.8M | Buy |
1,068,053
+53,965
| +5% | +$1.09M | 0.01% | 1270 |
|
|
2022
Q3 | $16.2M | Buy |
1,014,088
+7,897
| +0.8% | +$139K | 0.01% | 1466 |
|
|
2022
Q2 | $17.8M | Sell |
1,006,191
-4,421
| -0.4% | -$74.4K | 0.01% | 1444 |
|
|
2022
Q1 | $20.6M | Buy |
1,010,612
+11,090
| +1% | +$210K | 0.01% | 1499 |
|
|
2021
Q4 | $18.7M | Buy |
999,522
+39,017
| +4% | +$761K | ﹤0.01% | 1609 |
|
|
2021
Q3 | $19M | Sell |
960,505
-12,806
| -1% | -$277K | ﹤0.01% | 1599 |
|
|
2021
Q2 | $23M | Buy |
973,311
+42,286
| +5% | +$977K | 0.01% | 1531 |
|
|
2021
Q1 | $22.1M | Buy |
931,025
+247,848
| +36% | +$5.89M | 0.01% | 1469 |
|
|
2020
Q4 | $13.7M | Buy |
683,177
+139,268
| +26% | +$2.72M | ﹤0.01% | 1646 |
|
|
2020
Q3 | $11.3M | Sell |
543,909
-137,462
| -20% | -$2.48M | ﹤0.01% | 1596 |
|
|
2020
Q2 | $11.9M | Sell |
681,371
-16,098
| -2% | -$315K | ﹤0.01% | 1547 |
|
|
2020
Q1 | $11.4M | Buy |
697,469
+677,446
| +3,383% | +$14M | ﹤0.01% | 1475 |
|
|
2019
Q4 | $412K | Buy |
+20,023
| New | +$334K | ﹤0.01% | 3331 |
|
|
2019
Q2 | – | Sell |
-53,279
| Closed | -$807K | – | 3729 |
|
|
2019
Q1 | $807K | Sell |
53,279
-92,553
| -63% | -$1.48M | ﹤0.01% | 3127 |
|
|
2018
Q4 | $2.5M | Buy |
145,832
+120,780
| +482% | +$2.07M | ﹤0.01% | 2393 |
|
|
2018
Q3 | $370K | Sell |
25,052
-188,185
| -88% | -$3.34M | ﹤0.01% | 3551 |
|
|
2018
Q2 | $5.09M | Buy |
213,237
+20,663
| +11% | +$508K | ﹤0.01% | 2126 |
|
|
2018
Q1 | $4.92M | Buy |
+192,574
| New | +$4.59M | ﹤0.01% | 1968 |
|
|
2015
Q3 | – | Sell |
-310
| Closed | -$6K | – | 3824 |
|
|
2015
Q2 | $6K | Buy |
+310
| New | +$5.36K | ﹤0.01% | 4109 |
|
Other funds holding COLL
JT
EAM
RCMNY
Invesco's COLL Position: Q2 2026 in Review
Invesco increased its Collegium Pharmaceutical (COLL) stake by 18% in Q2 2026, buying an estimated $9.93M and bringing the position to 1,882,499 shares worth $68.1M. The position accounts for 0.01% of the portfolio, ranked #1023.
Invesco first reported a position in COLL in Q2 2015 and has held it in 33 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.
- Invesco held 1,882,499 shares of Collegium Pharmaceutical worth $68.1M as of Q2 2026.
- Invesco bought 290,590 Collegium Pharmaceutical shares in Q2 2026, an estimated $9.93M.
- Collegium Pharmaceutical made up 0.01% of Invesco's portfolio in Q2 2026, its #1023 holding.
- Invesco first reported a position in Collegium Pharmaceutical in Q2 2015 and has held it in 33 quarters since.
- 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.